[1] 肖英,栾森.血管紧张素Ⅱ受体1和二肽肌肽酶1基因多态性与糖尿病慢性肾脏疾病的相关性研究[J].中国糖尿病杂志,2015,23(6):497-500.DOI:10.3969/j.issn.1006-6187. 2015.06.005.
[2] 冯松青,赵佩英,吴琦.扫描式葡萄糖监测系统联合谷赖胰岛素治疗新诊断2型糖尿病患者血糖的临床观察[J].中国医药指南,2020,18(16):59-61. DOI: 10.15912/j.cnki.gocm.2020.16.025.
[3] 曹惠红.2型糖尿病患者血糖波动与血清胱抑素C的相关性研究[D]. 苏州:苏州大学,2018.
[4] Haas AV, Rosner BA, Kwong RY, et al. Sex differences in coronary microvascular function in individuals with type 2 diabetes[J]. Diabetes, 2019,68(3):631-636. DOI: 10.2337/db18-0650.
[5] Peters TM, Holmes MV, Richards JB, et al. Sex differences in the risk of coronary heart disease associated with type 2 diabetes: a mendelian randomization analysis[J]. Diabetes Care, 2021,44(2):556-562. DOI: 10.2337/dc20-1137.
[6] Noren Hooten N, Evans MK. Extracellular vesicles as signaling mediators in type 2 diabetes mellitus [J]. Am J Physiol Cell Physiol, 2020, 318(6):C1189-C1199.DOI:10.1152/ajpcell.00536.2019
[7] Goodarzi MO, Rotter JI. Genetics insights in the relationship between type 2 diabetes and coronary heart disease[J]. Circ Res, 2020,126(11):1526-1548. DOI: 10.1161/CIRCRESAHA.119.316065.
[8] 贾伟平. 中国糖尿病肾脏病防治指南(2021年版)[J]. 中华医学会糖尿病学分会, 2019, 10(1):4-8.DOI:10.3760/cma.j.cn115791-20210706-00369
[9] Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke[J]. Diabetes, 2021,70(2):627-637. DOI: 10.2337/db20-0800.
[10] Verma S, Mazer CD, Yan AT, et al. Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART cardiolink-6 randomized clinical trial[J]. Circulation, 2019,140(21):1693-1702. DOI: 10.1161/CIRCULATIONAHA. 119.042375.
[11] Arnold SV, Bhatt DL, Barsness GW, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the american heart association[J]. Circulation, 2020,141(19):e779-e806. DOI: 10.1161/CIR. 0000000000000766.
[12] Hoseini A, Namazi G, Farrokhian A, et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease[J]. Food Funct, 2019,10(9):6042-6051. DOI: 10.1039/c9fo01075k.
[13] Patsouras A, Farmaki P, Garmpi A, et al. Screening and risk assessment of coronary artery disease in patients with type 2 diabetes: an updated review[J]. In Vivo, 2019,33(4):1039-1049. DOI: 10.21873/invivo.11572.
[14] Ben Ahmed H, Bouzid K, Allouche E, et al. Relationship between Galectin-3 levels and severity of coronary artery disease in ST elevation myocardial infarction [J]. Tunis Med, 2020, 98(7):567-572.
[15] Yamamoto H, Shinke T, Otake H, et al. Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy [J]. J Diabetes Investig, 2021, 12(6):1015-1024. DOI:10.1111/jdi.13448.
[16] Wang R, Wang X, Zhang E, et al. Correlation of plasma galectin-3 and plasma lipoprotein-associated phospholipase A2 with the severity and prognosis of coronary artery disease [J]. Am J Transl Res, 2021, 13(8):8997-9004.
[17] Gong YY, Peng HY. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy[J]. Lipids in Health and Disease, 2021, 20(1):25.DOI:10.1186/s12944-021-01451-7.
[18] Hu Z, Yang M, Xie C, et al. Efficacy and safety of shenqi compound for the treatment of diabetic macroangiopathy: a protocol for systematic review and meta-analysis[J]. Medicine (Baltimore), 2020, 99(15):e19682. DOI: 10.1097/MD.0000000000019682.
[19] Gupta C, Bubber P, Fahim M, et al. Adiponectin in onset and progression of T2DM with cardiac dysfunction in rats[J]. Hum Exp Toxicol, 2020, 39(11):1463-1474. DOI: 10.1177/0960327120927446.
[20] Khandaker GM, Zuber V, Rees JMB, et al. Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort[J]. Mol Psychiatry, 2020,25(7):1477-1486. DOI: 10.1038/s41380-019-0395-3.
[21] Pinto LC, Rados DV, Remonti LR, et al. Patient-centered management of type 2 diabetes mellitus based on specific clinical scenarios: systematic review, meta-analysis and trial sequential analysis[J]. J Clin Endocrinol Metab, 2020, 105(11):dgaa534. DOI: 10.1210/clinem/dgaa534.
[22] 王惠,朱颖逸,董璐,等.基于Cite Space国内外糖尿病运动研究热点的可视化分析[J].国际医药卫生导报,2021,27(15):2216-2222.DOI:10.3760/cma.j.issn.1007-1245.2021. 15.001.
[23] Talari HR, Tabatabaei SMH, Soleimani A, et al. The effects of melatonin administration on carotid intima-media thickness and pulse wave velocity in diabetic nephropathy: a randomized, double-blind, placebo-controlled trial[J]. Clin Nutr ESPEN, 2022, 48:82-86. DOI: 10.1016/j.clnesp.2022.01.002.
[24] Yang T, Heng C, Zhou Y, et al. Corrigendum to 'Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis [Metabolism Clinical and Experimental 108 (2020) 154258][J]. Metabolism, 2022, 130:154963. DOI: 10.1016/j.metabol.2021.154963.
[25] Wen Y, Liu Y, Huang Q, et al. Corrigendum to "Moringa seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway" [Phytomedicine 95 (2022) 153856][J]. Phytomedicine, 2022, 100:154043. DOI: 10.1016/j.phymed.2022.154043.
[26] Carmona M, Paco-Meza LM, Ortega R, et al. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy[J]. Pathol Res Pract, 2022, 230:153756. DOI: 10.1016/j.prp.2021.153756.
[27] Jin J, Wang Y, Zheng D, et al. A novel identified circular RNA, mmu_mmu_circRNA_0000309, involves in germacrone-mediated improvement of diabetic nephropathy through regulating ferroptosis by targeting miR-188-3p/GPX4 signaling axis[J]. Antioxid Redox Signal, 2022, 36(10-12):740-759. DOI: 10.1089/ars.2021.0063.
|